Clinical Trial Update: Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on haploidentical transplant with post-transplant cyclophosphamide for Chronic Granulomatous Disease (CGD); study terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Granulomatous Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-05-01